Nektar Therapeutics
NKTR
#4933
Rank
S$2.33 B
Marketcap
S$83.34
Share price
-6.35%
Change (1 day)
432.53%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$10.39

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$10.08. In 2024 the company made an earnings per share (EPS) of S-$11.20 an increase over its 2023 EPS that were of S-$27.70.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$10.39-7.31%
2024S-$11.20-59.54%
2023S-$27.70-25.89%
2022S-$37.37-31.12%
2021S-$54.2514.86%
2020S-$47.23-1.19%
2019S-$47.80-163.96%
2018S$74.74-725.4%
2017S-$11.95-42.73%
2016S-$20.8783.33%
2015S-$11.3839.53%
2014S-$8.16-69.29%
2013S-$26.56-6.67%
2012S-$28.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.08-239.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.72-117.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.12-279.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$0.83-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.24-191.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$6.77-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.08852-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.62-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland